NIW国家利益豁免案例：生物统计方向博士生，无RFE直接获批
NIW Case Study: Biostatistics Ph.D. Candidate — Approved Without RFE

案例由新未名律所合伙人张媛媛律师 (Attorney Yuanyuan Zhang) 提供 |  yuanyuan.zhang@nwmlaw.com |  获批时间 Approval:2026年3月 (March 2026)

📌 一句话总结 TL;DR：
一位研究衰老与急性髓系白血病（AML）的生物统计方向申请人，在博士即将毕业时通过新未名律所递交NIW国家利益豁免申请（I-140），加急后于2026年3月无RFE（补件通知）直接获批。申请策略将人口老龄化与儿童癌症公共卫生需求有机结合，充分论证了国家利益。

A Biostatistics Ph.D. candidate researching aging and Acute Myeloid Leukemia (AML) was approved for an NIW (National Interest Waiver) petition withno RFE. Filed in October 2025 and upgraded to premium processing in February 2026, the case was directly approved in March 2026. The petition strategically linked public health needs in aging populations and pediatric oncology to demonstrate substantial national interest.

一、申请人背景是什么？ What Was the Applicant's Background?

这位申请人在提交NIW国家利益豁免申请（I-140）时，已持有生物统计学（Biostatistics）硕士学位，博士学业接近尾声、即将毕业。她的核心研究方向聚焦于衰老机制（Aging）与急性髓系白血病（Acute Myeloid Leukemia, AML）——这两个领域均处于当下生物医学研究的前沿，也是美国国立卫生研究院（NIH）的重点资助方向。

At the time of filing, the applicant held a Master's degree in Biostatistics and was nearing completion of her Ph.D. Her research centered on aging and Acute Myeloid Leukemia (AML) — two areas of pressing significance in biomedical science and prioritized by the National Institutes of Health (NIH).

二、NIW申请策略如何制定？ How Was the NIW Petition Strategy Designed?

新未名律所合伙人张媛媛律师在对申请人的学术履历和研究成果进行深度评估后，制定了以下双线并举的申请策略：

• 人口老龄化线（Aging Population）：美国及全球正面临前所未有的老龄化浪潮，申请人对衰老机制的研究有助于开发更精准的干预策略，直接服务于公共卫生与社会福利领域的国家利益。
  The applicant's aging research contributes to developing targeted interventions for the unprecedented aging demographic shift, serving clear national interest in public health policy.
• 儿童癌症诊疗线（Pediatric Oncology）：申请人与一家知名儿童医院（Children's Hospital）开展合作项目，致力于提升重症患儿（尤其是白血病患儿）的生存率（survival rate）及身心健康水平（physical and mental well-being）。申请材料着重呈现了这一合作的临床转化价值，契合公共卫生领域对儿童罕见疾病治疗优化的迫切需求（urgent need）。
  The applicant's collaboration with a children's hospital aimed at improving survival rates and overall well-being of critically ill pediatric patients. The petition highlighted the translational clinical value, aligning with urgent public health demands in pediatric rare disease treatment.

在论证 Matter of Dhanasar 三叉戟框架时，张律师将两条线索有机融合：申请人的工作兼具"实质性价值和全国性重要意义（substantial merit and national importance）"；申请人"有充分定位推进该事业（well positioned to advance the proposed endeavor）"；且"豁免劳工证要求（waiving the labor certification requirement）符合国家利益"。

Under the Matter of Dhanasar three-prong framework, Attorney Zhang wove both narratives together: the work carries substantial merit and national importance; the applicant is well positioned to advance the endeavor; and waiving the PERM labor certification requirement benefits the United States.

三、案件时间线与审理结果如何？ What Was the Case Timeline and Outcome?

申请人在提交I-140后经过慎重考虑，于2026年2月追加了加急处理（Premium Processing）。USCIS在15个工作日法定时限内即作出了直接批准（direct approval）决定，未发出任何RFE补件通知（Request for Evidence）或NOID拒绝意向通知（Notice of Intent to Deny）。

After careful deliberation, the applicant upgraded to Premium Processing in February 2026. USCIS rendered a direct approval within the statutory 15-business-day window in March 2026 — withno RFE and no NOID issued.

四、此案例对类似背景的申请人有什么启示？ What Can Similar Applicants Learn from This Case?

• 硕士学历也能申请NIW：NIW并不要求申请人已经获得博士学位。本案申请人在提交时仅持有硕士学位（博士在读），凭借清晰的研究贡献与合理的申请策略同样获批。对于正处于F-1 OPT阶段、J-1访问学者身份、或从H-1B转轨绿卡的留学生和博士后，NIW是一条值得尽早评估的路径。
  A Master's degree holder can file NIW. This applicant held only an M.S. at filing (Ph.D. pending). For those on F-1 OPT, J-1 status, or transitioning from H-1B, NIW merits early evaluation.
• 跨领域交叉叙事增强说服力：将衰老研究与儿童癌症诊疗两条线索交织，展示了更宽广的社会影响力，远比单一叙事更具冲击力。这对生物统计、公共卫生、流行病学、数据科学等交叉学科背景的申请人尤具参考意义。
  Cross-disciplinary storytelling — weaving aging research with pediatric oncology — demonstrated broader societal impact and proved more compelling than a single-track narrative.
• 医院/机构合作项目是强力证据：与儿童医院的合作项目提供了直接的"临床转化（translational）"证据，让移民官更容易理解研究的实际影响与国家利益关联。类似的合作（如与 NIH、大学医学中心、VA 系统等的联合项目）都可以成为 NIW 申请中的亮点。
  Institutional collaborations (e.g., with children's hospitals, NIH, VA systems) provide concrete translational evidence, making it easier for adjudicators to connect research to tangible national interest.
• 加急处理时机的选择：申请人并未在初始递交时即选择加急，而是在等待数月后综合考虑个人时间线（如博士毕业、OPT到期、优先日排期等）才追加加急。这种灵活策略在实操中十分常见，也适用于同时考虑 EB-1A杰出人才、EB-2/EB-3 PERM 等多条绿卡路径的申请人。
  The decision to upgrade to Premium Processing was made strategically — months after initial filing — to align with personal timeline considerations. This flexibility is common and useful for applicants concurrently exploringEB-1A, EB-2/EB-3 PERM, or other green card pathways.

五、为什么选择新未名律所办理NIW？ Why Choose New Weiming Law Group for NIW?

位于美国首都华盛顿地区的新未名律所，长年深耕服务大华府DMV地区（包括马里兰(Maryland)与弗吉尼亚(Virginia)）的华人社区、留学生、博士后及高科技/科研人员。无论您身处NIH-Bethesda、Johns Hopkins、UVA、Virginia Tech、UMD、Georgetown 还是 George Washington University等顶尖高校和研究机构，都能获得高度定制化的NIW、EB-1A、O-1、以及 H-1B/L-1/J-1豁免 等全线移民法律服务。

Located in the Washington, D.C. metropolitan area, New Weiming Law Group has served the Chinese community, international students, postdocs, and STEM professionals across the DMV area (Maryland & Virginia) for years. Whether you are at NIH, Johns Hopkins, UVA, Virginia Tech, UMD, Georgetown, or GWU, we offer highly customized immigration services including NIW, EB-1A, O-1, H-1B, L-1, J-1 waiver, and more.

本案主办律师张媛媛律师（yuanyuan.zhang@nwmlaw.com）在生物医学与统计交叉领域积累了丰富的NIW成功经验，擅长将复杂的科研成果转化为移民官可理解、可认可的法律论证。如果您的研究方向涉及生物统计、公共卫生、流行病学、基因组学、机器学习在医学中的应用等领域，欢迎联系咨询。

Lead attorney Yuanyuan Zhang has extensive NIW experience at the intersection of biomedical science and statistics, excelling at translating complex research into persuasive legal argumentation. If your field involves biostatistics, public health, epidemiology, genomics, or ML in medicine, we invite you to reach out.

© 2025 新未名律所 New Weiming Law Group. 本文仅供参考，不构成法律意见。This article is for informational purposes only and does not constitute legal advice.